Arash Assar, Jamie Walker, Mara Egeler, Veronica Floyd, Harrison Dickens, Ivan Vargas
{"title":"Estimating Public Knowledge About Cognitive Behavioral Therapy for Insomnia (CBT-I) and Alternative Treatments.","authors":"Arash Assar, Jamie Walker, Mara Egeler, Veronica Floyd, Harrison Dickens, Ivan Vargas","doi":"10.1080/15402002.2025.2610674","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study assessed public knowledge about insomnia treatments, particularly Cognitive Behavioral Therapy for Insomnia (CBT-I), and examined whether familiarity varied by gender or race. The primary aim was to quantify what proportion of adults in the United States are familiar with and use CBT-I.</p><p><strong>Methods: </strong>A nationally representative sample of 3080 U.S. adults (<i>M<sub>age</sub> </i>= 39.5 years, <i>SD<sub>age</sub> </i>= 12.9) was surveyed. Approximately 48.3% identified as women. Participants reported their familiarity with various insomnia treatments, including pharmacological and behavioral options, and whether they had used prescription medications, over-the-counter sleep aids, or CBT-I within the past year or at any point in their lifetime.</p><p><strong>Results: </strong>Participants were substantially more familiar with pharmacological treatments than behavioral therapies, with notably low recognition of CBT-I. Treatment utilization patterns supported that people tend to have a greater reliance on pharmacological interventions, particularly over-the-counter options, than CBT-I. Demographic differences emerged, with women and White participants reporting greater awareness of insomnia treatments than men and individuals from other racial groups. Age related differences were also observed, though, these varied by treatment approach.</p><p><strong>Conclusions: </strong>This study identified major gaps in public awareness of CBT-I and highlighted disparities in treatment knowledge. Addressing these gaps is critical for improving treatment access and promoting CBT-I as a first-line, evidence-based treatment for insomnia.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"330-345"},"PeriodicalIF":1.6000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12797138/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioral Sleep Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15402002.2025.2610674","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study assessed public knowledge about insomnia treatments, particularly Cognitive Behavioral Therapy for Insomnia (CBT-I), and examined whether familiarity varied by gender or race. The primary aim was to quantify what proportion of adults in the United States are familiar with and use CBT-I.
Methods: A nationally representative sample of 3080 U.S. adults (Mage= 39.5 years, SDage= 12.9) was surveyed. Approximately 48.3% identified as women. Participants reported their familiarity with various insomnia treatments, including pharmacological and behavioral options, and whether they had used prescription medications, over-the-counter sleep aids, or CBT-I within the past year or at any point in their lifetime.
Results: Participants were substantially more familiar with pharmacological treatments than behavioral therapies, with notably low recognition of CBT-I. Treatment utilization patterns supported that people tend to have a greater reliance on pharmacological interventions, particularly over-the-counter options, than CBT-I. Demographic differences emerged, with women and White participants reporting greater awareness of insomnia treatments than men and individuals from other racial groups. Age related differences were also observed, though, these varied by treatment approach.
Conclusions: This study identified major gaps in public awareness of CBT-I and highlighted disparities in treatment knowledge. Addressing these gaps is critical for improving treatment access and promoting CBT-I as a first-line, evidence-based treatment for insomnia.
期刊介绍:
Behavioral Sleep Medicine addresses behavioral dimensions of normal and abnormal sleep mechanisms and the prevention, assessment, and treatment of sleep disorders and associated behavioral and emotional problems. Standards for interventions acceptable to this journal are guided by established principles of behavior change. Intending to serve as the intellectual home for the application of behavioral/cognitive science to the study of normal and disordered sleep, the journal paints a broad stroke across the behavioral sleep medicine landscape. Its content includes scholarly investigation of such areas as normal sleep experience, insomnia, the relation of daytime functioning to sleep, parasomnias, circadian rhythm disorders, treatment adherence, pediatrics, and geriatrics. Multidisciplinary approaches are particularly welcome. The journal’ domain encompasses human basic, applied, and clinical outcome research. Behavioral Sleep Medicine also embraces methodological diversity, spanning innovative case studies, quasi-experimentation, randomized trials, epidemiology, and critical reviews.